Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
Clinical trial NCT04525326 · UNKNOWN
Trial details
- NCT number
- NCT04525326
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2022-10-01
- Enrollment
- 584
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.